NCT05627219

Brief Summary

This trial evaluates whether a network of peer genetic coaches is useful for addressing disparities in genetic testing and screening among African American men with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). While genetic testing has become central to prostate cancer care, African American men are less likely seek testing due to lack of awareness, cultural beliefs, financial limitations, fear of discrimination, and mistrust in the healthcare system. A network of peer genetic coaches may help address barriers, beliefs, and needs of African American men in the community and provide navigation to increase engagement in genetic testing.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 25, 2022

Completed
1.5 years until next milestone

Study Start

First participant enrolled

June 3, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2026

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

1.9 years

First QC Date

November 16, 2022

Last Update Submit

May 15, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Number of inquiries to the central number (feasibility)

    Up to 1 year

  • Percent of callers screened and eligible to participate (feasibility)

    Up to 1 year

  • Percent of eligible callers who enroll in the study (feasibility)

    Up to 1 year

  • Percent who complete the endpoint assessment (feasibility)

    Up to 1 year

  • Number and percent of men making genetic counseling appointments

    Up to 1 year

Secondary Outcomes (3)

  • Change in decisional conflict for genetic counseling

    Baseline up to 1 year

  • Change in acceptability/attitude toward genetic counseling and testing

    Baseline up to 1 year

  • Change of genetics knowledge

    Baseline up to 1 year

Study Arms (1)

Supportive care (training, education, discussion)

AIM 1: Peer genetic coaches undergo training and education on study. AIM 2: Patients receive an educational booklet and attend a discussion with a peer genetic coach on study.

Behavioral: Training and EducationOther: Educational InterventionProcedure: Discussion

Interventions

Undergo training and education

Supportive care (training, education, discussion)

Receive educational booklet

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Supportive care (training, education, discussion)
DiscussionPROCEDURE

Attend discussion with peer genetic coach

Also known as: Discuss
Supportive care (training, education, discussion)

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men who have experience with both prostate cancer (PCA) and genetic counseling and testing, as well as peer education or navigation experience. African American men with a history of prostate cancer or with a strong family history of prostate cancer, breast cancer, ovarian cancer, pancreatic cancer, colorectal cancer, uterine cancer, renal cancer, urothelial cancer, or upper bowel cancer.

You may qualify if:

  • AIM 1: Are 18 years old or older
  • AIM 1: Are able to read and speak English comfortably
  • AIM 1: Men who have experience with both prostate cancer (PCA) and genetic counseling and testing will be a priority for training, as well as men who have considerable peer education or navigation experience
  • AIM 2: Are 18 years old or older
  • AIM 2: Are African American
  • AIM 2: Are able to read and speak English comfortably
  • AIM 2: Men who meet any one of the following criteria: (1) metastatic prostate cancer; (2) prostate cancer with high-risk features (T3 or higher, Gleason 8 or higher, node positive disease); (3) with or without a diagnosis of prostate cancer with strong family history (2 or more first-degree or second-degree relatives) with prostate cancer (particularly metastatic prostate cancer or died from prostate cancer), breast cancer, ovarian cancer, pancreatic cancer, colorectal cancer, uterine cancer, renal cancer, urothelial cancer, or upper bowel cancer

You may not qualify if:

  • Children under the age of 18
  • Anyone who has trouble understanding the consent or with significant anxiety detected during the consent process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

RECRUITING

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Educational StatusEarly Intervention, EducationalMethods

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation CharacteristicsChild Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesInvestigative Techniques

Study Officials

  • Amy Leader, DrPh, MPH

    Thomas Jefferson University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amy Leader, DrPh, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2022

First Posted

November 25, 2022

Study Start

June 3, 2024

Primary Completion

April 29, 2026

Study Completion

April 29, 2026

Last Updated

May 20, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations